 Future developments nonhormonal systemic therapy prostatic carcinoma Prostate cancer common type cancer men increased public awareness new methods significant proportion men metastatic disease men hormonal intervention time majority recurrences unresponsive tumor present therapies little impact Research new cellular molecular aspects prostate cancer implications possible sites therapeutic intervention